Median Technologies is awarded the Euronext European Rising Tech Label

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With iBiopsy® we are disrupting the management of serious diseases such as lung cancer, liver cancer, and NASH. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. iBiopsy® is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

Press Release – For immediate release – 5:45 pm CEST

Median Technologies is awarded the Euronext European Rising Tech Label

With this label, the Euronext committee recognizes Median Technologies’ solid economic and stock market performance

Median Technologies, The Imaging Phenomics Company® (ALMDT) announced today that it has been awarded the Euronext European Rising Tech Label.

The European Rising Tech Label recognizes 98 top-performing companies among more than 350 small and mid-caps listed on Euronext markets in Amsterdam, Brussels, Dublin, Lisbon and Paris, in the Tech sector (i.e., Life Sciences, Clean Tech and Technology, Media & Telecom).

As of May 31^st, 2020, these 98 companies had a market capitalization of €23 billion, for €21 billion traded in one year. This confirms the enthusiasm of investors for Tech companies listed on the Euronext.

Back to press releases